We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
  • 04-242.png
Medical Device Reg. No. 20262400410 (Guangdong)

Phosphorylated Tau 181 Protein (p-Tau 181) Assay Kit

The tau protein series of biomarkers holds significant value in the diagnosis of AD. Specifically, p-Tau 217 and p-Tau 181 specifically identify the phosphorylation status of tau protein and are closely associated with neurofibrillary tangles in AD. Notably, pTau217 has become a star biomarker in AD blood testing due to its high sensitivity and specificity for early diagnosis. These biomarkers can not only assist in the diagnosis of AD but also monitor disease progression and evaluate therapeutic efficacy, providing an important basis for personalized medicine.

  • Complete Product Line

    Offers a comprehensive product series to fully meet clinical multi-marker diagnostic needs based on the “A+T+N” standard

  • Leading Performance

    Optimized with self-developed core raw materials, sensitivity reaches sub-pg level.

  • High Automation, Rapid Testing

    Integrated with a high-performance fully automated instrument platform, single-tube loading; first report in 20 min.

  • Stable and Fast Results

    Testing throughput up to 200 T/H, intra-batch CV ≤ 8%, inter-batch CV ≤ 15%

  • Economic Advantage

    The overall solution offers significant cost advantages, effectively reducing the operational burden on medical institutions.

image.png